Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
GRUPHA
Grunenthal GmbH€300
1EMEA
Apr 18, 2023
currency
EUR
size (m)
300.000
maturity
May 15, 2030
type
Fixed
tenor
7.000
call
3
registration
144A/Reg S
benchmark
-
ranking
Sr. Secured
moody's
B1
s&p
BB-
fitch
BB+
size description
-
re-open/tap
No
ipt
-
ipt-pxd
-
guidance
6.75%-7.00%
spread
432
coupon
6.750%
spread set
-
price
100.00000
yield
6.750%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
DEU, GSC, ING, RBC, ...
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
DEU, GSC, ING, RBC, ...
joint leads
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
Redemption: 2026-05-15; Registration: 144A/Reg S;
Deal Comments
04/18/2023 Grunenthal GmbH (GRUPHA) EUR300m 144A/Reg S sr sec 1st lien notes due 05/15/30 (7y). NC3 (MWC B+50bp), then at 103.375, 101.688, 100. Equity claw: 3y 40% at 106.75. B1/BB-/BB+ (positive/stable/stable). Via DB (B&D)/GS/ING/RBC/UniCredit jt glocos/Commerz/BNP jt bks. No reg rights. List ISE. NY law. Settles 04/25 (T+5). Reg S ISIN: XS2615562274. Px talk: 6.75%-7.00%. Priced: 6.75% at 100. +432bp vs DBR 0% 02/15/30. Roadshow 04/17-18 (investor call at 11am UKT 04/18). Books closed at 2:30pm UKT 04/18. UOP: refinance the EUR200m Neon bridge loan facility incurred to fund the EUR494m acquisition of Nebido from Bayer AG on 11/22/22, repay EU75m Schuldschein private placement promissory notes, GCP. Wholly-owned by the Wirtz family. Biz: Leading innovator in pain treatments. HQ: Aachen, Germany.

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.